Electroacupuncture
Molecular Medicine Reports · Lin et al. · 2016 · 40 participants
Electroacupuncture at the Baihui acupoint alleviates cognitive impairment and exerts neuroprotective effects by modulating the expression and processing of brain-derived neurotrophic factor in APP/PS1 transgenic mice
Weak
Limited
Moderate
Strong
- Wild-type control (WT)10 participants
- APP/PS1 control10 participants
p < 0.01
Reduction in escape time in the water maze
p < 0.01
Decrease in beta-amyloid (1-42) deposition
p < 0.01
Reduction in neuronal apoptosis (TUNEL-positive)
Study design sheet
- Controlled Experimental Study
- n=40 mice
- APP/PS1 Transgenic Model
- Participants
- 40
- Duration
4 weeks
4 weeks of treatment with daily electroacupuncture for 30 minutes
- Groups
- Wild-type control (WT) (10)No treatment
- APP/PS1 control (10)No treatment
- APP/PS1 + GV-20 (10)Electroacupuncture at the Baihui point
- APP/PS1 + sham point (10)Electroacupuncture at non-acupoint
- OBJECTIVE
- To investigate the neuroprotective effects of electroacupuncture at the Baihui point (GV-20) on cognitive deficits in APP/PS1 transgenic mice, an Alzheimer's disease model
- WHO
- 30 APP/PS1 transgenic mice (3 months old) and 10 controls, divided into 4 groups
- POINTS
- Baihui (GV-20) — located at the intersection of the sagittal line and the line connecting the two ears
- Results in numbers
- p < 0.01Reduction in escape time in the water maze
- p < 0.01Decrease in beta-amyloid (1-42) deposition
- p < 0.01Reduction in neuronal apoptosis (TUNEL-positive)
- p < 0.01Increase in BDNF/proBDNF ratio
What does this mean for you?
This study showed that electroacupuncture at the Baihui point can improve memory and protect neurons in an animal model of Alzheimer's disease. The treatment increased an important protein for brain health (BDNF) and reduced the buildup of toxic proteins, suggesting therapeutic potential for neurodegenerative diseases.
Article summary
Plain-language narrative summary
This experimental study investigated the neuroprotective effects of electroacupuncture at the Baihui point (GV-20) in APP/PS1 transgenic mice, a well-established model of Alzheimer's disease. The research was motivated by the traditional use of this specific point in Chinese medicine to treat cognitive deficits, although the underlying mechanisms remained poorly understood. The study used 40 mice divided into four groups: wild-type control, untreated APP/PS1, APP/PS1 treated with electroacupuncture at Baihui, and APP/PS1 treated at a sham point. The protocol consisted of daily 30-minute sessions for 4 weeks, using dispersive waves at 1 and 20 Hz.
Cognitive assessment was performed using the Morris water maze test, which assesses spatial learning and memory. The results demonstrated that APP/PS1 mice showed significant learning and memory deficits, with longer escape times and lower frequency of crossing the original platform location. Notably, electroacupuncture at Baihui significantly reversed these deficits, while sham-point treatment produced no benefits. Pathologic analysis revealed important mechanisms: electroacupuncture attenuated beta-amyloid (1-42) deposition in the hippocampus, one of the main pathologic features of Alzheimer's.
Simultaneously, there was a significant reduction in neuronal apoptosis, evidenced by the decrease in TUNEL-positive cells. According to the authors, electroacupuncture may exert neuroprotective effects by modulating the expression and processing of brain-derived neurotrophic factor (BDNF), although the mechanism remains to be elucidated. Electroacupuncture increased levels of both mature BDNF and proBDNF, but crucially raised the BDNF/proBDNF ratio, indicating more efficient processing of the protein. This distinction is fundamental, because mature BDNF promotes neuronal survival through the TrkB receptor, whereas proBDNF can induce apoptosis via the p75NTR receptor.
Consistently, the treatment increased TrkB phosphorylation and reduced p75NTR expression, suggesting a shift in signaling balance in favor of neuroprotection. The clinical implications are promising, considering that BDNF is decreased in patients with Alzheimer's and correlates positively with cognitive function. The ability of electroacupuncture to modulate this system represents a biologically plausible mechanism for its therapeutic effects. The study presents methodologic strengths, including the use of a validated transgenic model, appropriate control groups, and comprehensive biomarker analysis.
Limitations include the animal model (which may not fully replicate the complexity of human disease), relatively small sample size, and the need for validation in clinical studies. The specificity of the Baihui point was partially confirmed by the absence of effects with sham-point stimulation, although comparisons with other acupoints would strengthen this conclusion.
Strengths
- Use of well-validated APP/PS1 transgenic model for Alzheimer's
- Comprehensive analysis including behavior, pathology, and molecular biomarkers
- Analysis of the BDNF/proBDNF pathway as a possible mechanism, still to be elucidated
- Appropriate sham-point control demonstrating specificity
Limitations
- Animal model may not fully replicate the complexity of human Alzheimer's disease
- Relatively small sample size (n=10 per group)
- Lack of comparison with other acupoints or standard treatments
- Need for validation in human clinical studies

Expert Commentary
Clinical Relevance
Alzheimer's disease remains one of the greatest therapeutic challenges in neurology and cognitive rehabilitation, with a pharmacologic arsenal that improves symptoms and delays progression only to a certain extent, without stopping or reversing it. This study in an APP/PS1 transgenic model offers mechanistic substrate for a nonpharmacologic approach already used empirically in neurologic rehabilitation services. The modulation of the BDNF/proBDNF pathway by electroacupuncture at GV-20 is directly relevant to the physiatrist who treats patients with mild cognitive impairment or early dementia, often in combination with cognitive stimulation programs and aerobic exercise — both with already documented BDNF-dependent effects. The authors conclude that electroacupuncture at Baihui may be a promising treatment strategy for Alzheimer's disease; efficacy was evaluated only in animal models, and application in human patients depends on clinical studies.
Notable Findings
The most relevant finding is not the cognitive improvement per se, but the mechanism by which it occurs: electroacupuncture at Baihui not only raised total BDNF levels but shifted the proteolytic balance in favor of mature BDNF, increasing the BDNF/proBDNF ratio. This distinction is neurophysiologically critical — mature BDNF signals through TrkB, promoting synaptic plasticity and neuronal survival, while proBDNF activates p75NTR in a pro-apoptotic direction. The treatment increased TrkB phosphorylation and reduced p75NTR expression simultaneously, suggesting coordinated modulation of the system, not just nonspecific upregulation of gene expression. Equally noteworthy is the specificity of the point: the sham-point group did not show the same benefits, which strengthens the hypothesis that the location of GV-20 over the cranial vertex has functional relevance.
From My Experience
In my neurologic rehabilitation practice, I have incorporated electroacupuncture at GV-20 into protocols for post-stroke patients with cognitive deficits and, more recently, in cases of mild cognitive impairment referred by neurology. The response I usually observe is not dramatic in the first sessions — the patient's family member usually notices something only after the third or fourth week of consistent treatment, which is consistent with the four-week protocol used in this study. I typically maintain cycles of 8 to 12 sessions, with neuropsychological reassessment at the end, and I consistently combine treatment with supervised aerobic exercise, given the synergistic effect on BDNF that the literature already documents. Patients who respond best, in my experience, are those at an early stage, with good cognitive reserve and adherence to the global program. I avoid recommending it as monotherapy — electroacupuncture has an adjuvant, not substitutive, role within a structured rehabilitation plan.
Dr. Marcus Yu Bin Pai · MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.
Full original article
Read the full scientific study
Molecular Medicine Reports · 2016
DOI: 10.3892/mmr.2015.4751
Scientific review
Dr. Marcus Yu Bin PaiScientific lead · CRM-SP 158074 · RQE 65523 · 65524 · 655241
Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
- Strong
- Moderate
- Limited
- Weak
See the numbers: This study among the Library’s studies
| Study design | Electroacupuncture | All studies |
|---|---|---|
| Meta-analysis · Systematic Review | 21 | 387 |
| RCT | 26 | 224 |
| Clinical Guideline | 1 | 5 |
| Observational | 0 | 38 |
| Case Series | 1 | 7 |
| Narrative Review | 8 | 155 |
| Preclinical / Animal | 4 | 6 |
| Other | 24 | 203 |
Related articles
Based on this article’s categories
Napadow et al. · Cerebral Cortex · 2014
- Mechanisms of Action
- Neurology & Stroke Rehab
- Electroacupuncture
Kim et al. · PLoS ONE · 2013
- Electroacupuncture
- Neurology & Stroke Rehab
- Mechanisms of Action
Maeda et al. · Brain · 2017
- Electroacupuncture
- Mechanisms of Action
Hui et al. · Autonomic Neuroscience · 2010
- Mechanisms of Action
- Chronic Pain
- Neurology & Stroke Rehab